Investigations on the membrane interaction of C-terminally amidated esculentin-2 HYba1 and 2 peptides against bacteria

References

• Scocchi M, Mardirossian M, Runti G, et al. Non-membrane permeabilizing modes of action of antimicrobial peptides on bacteria. Curr Top Med Chem. 2016;16(1):76–88.
   PubMed Web of Science ®Google Scholar
• Vineethkumar TV, George S. A review of the mechanism of action of amphibian antimicrobial peptides focusing on peptide-membrane interaction and membrane curvature. Curr Protein Pept Sci. 2017;18(12):1263–1272.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacogn Rev. 2003;55(1):7–55.
   Web of Science ®Google Scholar
• König E, Bininda-Emonds OR, Shaw C. The diversity and evolution of anuran skin peptides. Peptides. 2015;63:96–117.
   PubMed Web of Science ®Google Scholar
• Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3(3):238–250.
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Sugishita KI, Harada M, et al. Interactions of an antimicrobial peptide, magainin-2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta Biomembr. 1997;1327(1):119–130.
   Web of Science ®Google Scholar
• Juretić D, Vukičević D, Petrov D, et al. Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides. Eur Biophys J. 2011;40(4):371–385.
   PubMed Web of Science ®Google Scholar
• Mangoni ML, Luca V, McDermott AM. Fighting microbial infections: a lesson from amphibian skin-derived esculentin-1 peptides. Peptides 2015;71:286–295.
   PubMed Web of Science ®Google Scholar
• Vineethkumar TV, Asha R, Shyla G, et al. Studies on the mode of membrane interaction of C-terminally amidated brevinin1 HYba1 and 2 peptides against bacteria. Int J Pept Res Ther. 2018;24(1):117–129.
   Web of Science ®Google Scholar
• Nuding S, Fellermann K, Wehkamp J, et al. A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J Microbiol Methods. 2006;65(2):335–345.
   PubMed Web of Science ®Google Scholar
• Wu G, Ding J, Li H, et al. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332. Curr Microbiol. 2008;57(6):552–557.
   PubMed Web of Science ®Google Scholar
• Luca V, Stringaro A, Colone M, et al. Esculentin (1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. Cell Mol Life Sci. 2013;70(15):2773–2786.
   PubMed Web of Science ®Google Scholar
• Makovitzki A, Avrahami D, Shai Y. Ultrashort antibacterial and antifungal lipopeptides. Proc Natl Acad Sci USA. 2006;103(43):15997–16002.
   PubMed Web of Science ®Google Scholar
• Mangoni ML, Papo N, Barra D, et al. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli . Biochem J. 2004;380 (Part 3):859–865.
   PubMedGoogle Scholar
• Abraham P, George S, Kumar KS. Novel antibacterial peptides from the skin secretion of the Indian bicoloured frog Clinotarsus curtipes. Biochimie 2014;97:144–151.
   PubMed Web of Science ®Google Scholar
• Abraham P, Sundaram A, Asha R, et al. Structure-activity relationship and mode of action of a frog secreted antibacterial peptide B1CTcu5 using synthetically and modularly modified or deleted (SMMD) peptides. PloS One. 2015;10(5):e0124210.
   PubMed Web of Science ®Google Scholar
• Marcellini L, Borro M, Gentile G, et al. Esculentin‐1b (1–18) – a membrane‐active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. Febs J. 2009;276(19):5647–5664.
   PubMed Web of Science ®Google Scholar
• Tiozzo E, Rocco G, Tossi A, et al. Wide-spectrum antibiotic activity of synthetic, amphipathic peptides. Biochem Biophys Res Commun. 1998;249(1):202–206.
   PubMed Web of Science ®Google Scholar
• da Silva AV, De Souza BM, dos Santos Cabrera MP, et al. The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems. Biochim Biophys Acta. 2014;1838(10):2357–2368.
   PubMed Web of Science ®Google Scholar
• Thomas KJ, Rice CV. Revised model of calcium and magnesium binding to the bacterial cell wall. Biometals. 2014;27(6):1361–1370.
   PubMed Web of Science ®Google Scholar
• Huang J, Hao D, Chen Y, et al. Inhibitory effects and mechanisms of physiological conditions on the activity of enantiomeric forms of an α-helical antibacterial peptide against bacteria. Peptides. 2011;32(7):1488–1495.
   PubMed Web of Science ®Google Scholar